Christopher D M Fletcher Selected Research

Leiomyosarcoma

1/2023	GLI1 Immunohistochemistry Distinguishes Mesenchymal Neoplasms With GLI1 Alterations From Morphologic Mimics.
1/2022	Pulmonary "Inflammatory Leiomyosarcomas" Are Indolent Tumors With Diploid Genomes and No Convincing Rhabdomyoblastic Differentiation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher D M Fletcher Research Topics

Disease

116	Neoplasms (Cancer) 05/2024 - 01/2002
23	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2023 - 02/2002
16	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 06/2003
7	Carcinoma (Carcinomatosis) 01/2018 - 09/2003
5	Benign Fibrous Histiocytoma (Dermatofibroma) 10/2023 - 01/2002
5	Melanoma (Melanoma, Malignant) 11/2022 - 02/2005
5	Neurofibrosarcoma (MPNST) 10/2020 - 01/2010
4	Perivascular Epithelioid Cell Neoplasms 01/2024 - 09/2009
4	Carcinogenesis 01/2023 - 05/2004
4	Liposarcoma 01/2023 - 02/2005
4	Fibrosarcoma 01/2021 - 05/2011
4	Myoepithelioma 10/2019 - 09/2003
3	Disease Progression 05/2024 - 09/2009
3	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2007
3	Necrosis 01/2018 - 10/2008
3	Genetic Translocation (Chromosomal Translocation) 10/2015 - 12/2002
3	Fasciitis (Fascitis) 10/2008 - 06/2002
2	Myxoma (Myxomas) 11/2023 - 07/2009
2	Angiofibroma 10/2023 - 05/2012
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2023 - 04/2014
2	Leiomyosarcoma 01/2023 - 01/2022
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2018
2	Fibrosis (Cirrhosis) 01/2021 - 02/2004
2	Hemangioendothelioma 12/2020 - 05/2017
2	Hemangiosarcoma (Angiosarcoma) 01/2019 - 08/2005
2	Angiomyolipoma 02/2018 - 09/2009
2	Myopericytoma 08/2017 - 06/2017
2	Hemangiopericytoma 06/2017 - 05/2011
2	Synovial Sarcoma (Synovioma) 06/2017 - 10/2016
2	Neurofibroma 01/2017 - 01/2010
2	Neurilemmoma (Schwannoma) 05/2015 - 09/2007
2	Tuberous Sclerosis (Bourneville's Disease) 02/2010 - 09/2009
2	Nerve Sheath Neoplasms (Nerve Sheath Neoplasm) 09/2007 - 07/2005
1	Adenosarcoma 01/2023
1	Seminoma 01/2023
1	Osteosarcoma (Osteogenic Sarcoma) 01/2023
1	Sertoli Cell Tumor 12/2022
1	Rhabdomyoma 12/2022
1	Clear Cell Sarcoma 11/2022
1	Malignant Mesothelioma 07/2022

Drug/Important Bio-Agent (IBA)

23	DesminIBA 05/2024 - 11/2004
22	Imatinib Mesylate (Gleevec)FDA Link 05/2024 - 02/2002
19	S100 Proteins (S 100 Protein)IBA 02/2023 - 11/2004
17	Keratins (Keratin)IBA 01/2022 - 01/2004
16	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2002
15	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 07/2004
14	RNA (Ribonucleic Acid)IBA 10/2023 - 03/2005
14	Mucin-1 (CA 15-3 Antigen)IBA 01/2023 - 01/2002
13	Phosphotransferases (Kinase)IBA 11/2023 - 01/2003
11	CollagenIBA 12/2018 - 01/2002
8	Calmodulin-Binding Proteins (Caldesmon)IBA 11/2023 - 07/2005
8	ChromatinIBA 01/2023 - 09/2003
8	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2008 - 04/2002
6	CateninsIBA 11/2023 - 06/2017
5	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2024 - 06/2003
5	MART-1 AntigenIBA 01/2024 - 04/2008
5	beta CateninIBA 12/2023 - 02/2006
4	Sunitinib (Sutent)FDA Link 05/2024 - 11/2008
4	CAM 5.2 antigenIBA 01/2023 - 12/2007
4	SynaptophysinIBA 01/2023 - 01/2006
4	Messenger RNA (mRNA)IBA 10/2016 - 10/2004
4	ParaffinIBA 01/2016 - 07/2004
4	Neurofilament ProteinsIBA 10/2009 - 07/2005
3	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 05/2024 - 07/2015
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 11/2023 - 12/2003
3	Protein Isoforms (Isoforms)IBA 11/2023 - 12/2003
3	Inhibins (Inhibin)IBA 11/2023 - 01/2014
3	ChromograninsIBA 01/2023 - 01/2006
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 10/2015
3	Microphthalmia-Associated Transcription FactorIBA 02/2018 - 04/2008
3	Capsules (Microcapsules)IBA 08/2017 - 09/2007
3	Formaldehyde (Formol)FDA Link 01/2016 - 07/2013
3	Monoclonal AntibodiesIBA 07/2015 - 03/2009
3	Phosphopyruvate Hydratase (Enolase)IBA 01/2014 - 01/2006
3	Oncogene Proteins (Oncogene Protein)IBA 03/2013 - 01/2003
3	Claudin-1IBA 10/2009 - 07/2005
3	Tyrosine Kinase InhibitorsIBA 03/2009 - 08/2002
3	Glial Fibrillary Acidic ProteinIBA 07/2008 - 07/2005
2	Cyclin D1IBA 05/2024 - 01/2020
2	Collagen Type I (Type I Collagen)IBA 01/2023 - 06/2011
2	Biomarkers (Surrogate Marker)IBA 07/2022 - 02/2018
2	Cathepsin KIBA 01/2022 - 02/2018
2	Sirolimus (Rapamycin)FDA Link 01/2018 - 02/2010
2	MicroRNAs (MicroRNA)IBA 10/2016 - 01/2010
2	LigandsIBA 04/2016 - 07/2013
2	AntibodiesIBA 09/2015 - 07/2013
2	Platelet-Derived Growth FactorIBA 06/2011 - 10/2006
2	Complementary DNA (cDNA)IBA 12/2010 - 09/2002
2	HemosiderinIBA 02/2006 - 02/2004
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2005 - 07/2004
1	Melanins (Melanin)IBA 01/2024
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 10/2023
1	Untranslated RNA (Noncoding RNA)IBA 01/2023
1	Keratin-1IBA 01/2023
1	Cadherins (E-Cadherin)IBA 01/2022

Therapy/Procedure

19	Therapeutics 05/2024 - 04/2002
8	Drug Therapy (Chemotherapy) 05/2024 - 06/2002
3	Aftercare (After-Treatment) 01/2019 - 05/2006
3	Radiotherapy 01/2017 - 08/2005
1	Orchiectomy (Orchidectomy) 12/2022